Balentine LLC’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-44,035
| Closed | -$646K | – | 478 |
|
|
2024
Q1 | $646K | Buy |
44,035
+1,145
| +3% | +$16.8K | 0.02% | 247 |
|
|
2023
Q4 | $597K | Buy |
42,890
+9,620
| +29% | +$134K | 0.02% | 249 |
|
|
2023
Q3 | $445K | Sell |
33,270
-55
| -0.2% | -$736 | 0.01% | 284 |
|
|
2023
Q2 | $421K | Buy |
33,325
+3,130
| +10% | +$39.5K | 0.01% | 310 |
|
|
2023
Q1 | $344K | Sell |
30,195
-1,895
| -6% | -$21.6K | 0.01% | 373 |
|
|
2022
Q4 | $332K | Buy |
32,090
+5,210
| +19% | +$53.9K | 0.01% | 423 |
|
|
2022
Q3 | $281K | Sell |
26,880
-9,640
| -26% | -$101K | 0.01% | 410 |
|
|
2022
Q2 | $405K | Buy |
36,520
+7,040
| +24% | +$78.1K | 0.01% | 359 |
|
|
2022
Q1 | $329K | Buy |
+29,480
| New | +$329K | 0.01% | 404 |
|
|
2021
Q3 | – | Sell |
-15,720
| Closed | -$231K | – | 342 |
|
|
2021
Q2 | $231K | Buy |
+15,720
| New | +$231K | 0.01% | 148 |
|
|
2020
Q3 | – | Sell |
-9,140
| Closed | -$97K | – | 692 |
|
|
2020
Q2 | $97K | Buy |
+9,140
| New | +$97K | 0.01% | 155 |
|
|
2019
Q4 | – | Sell |
-3,290
| Closed | -$25K | – | 718 |
|
|
2019
Q3 | $25K | Buy |
3,290
+585
| +22% | +$4.45K | ﹤0.01% | 213 |
|
|
2019
Q2 | $20K | Buy |
2,705
+595
| +28% | +$4.4K | ﹤0.01% | 210 |
|
|
2019
Q1 | $17K | Buy |
2,110
+1,215
| +136% | +$9.79K | ﹤0.01% | 218 |
|
|
2018
Q4 | $7K | Hold |
895
| – | – | ﹤0.01% | 287 |
|
|
2018
Q3 | $6K | Buy |
+895
| New | +$6K | ﹤0.01% | 313 |
|